<DOC>
	<DOC>NCT00373568</DOC>
	<brief_summary>Miltefosine (longer course) will be used to try to improve the cure rate of mucosal leishmaniasis</brief_summary>
	<brief_title>Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis</brief_title>
	<detailed_description>Miltefosine (42 days) will be used to try to improve upon the cure rate with 28 days of drug for bolivian mucosal leishmaniasisi</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Miltefosine</mesh_term>
	<criteria>Mucosal leishmaniasis No comcomitant disease as judged by laboratory and clinical parameters</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>mucosal</keyword>
	<keyword>miltefosine</keyword>
</DOC>